Sreoshi Chatterjee 452 posts 0 comments

CE Mark approval was sought for EPD's Cardiac Mapping and Navigation System. The system helps electrophysiologists navigate the heart by generating a succinct 3D Map while imaging and…
Read More...

Leading Science and technology company, Merck announced that the Argentinian Administration of Medicines, Food and Medical Technology has sanctioned the registration of MAVENCLAD …
Read More...

Atrium Health's Levine Children's Hospital proved to be a new trial site to test a new medicine for children that can regulate and stabilize their blood pressure in fatal circumstances.…
Read More...

Genomics England and Lantern Pharma that emphasizes on precision oncology incorporating Artificial intelligence asserted that Lantern will associate with Genomics England's Discovery…
Read More...

Amgen asserted that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the current indication for…
Read More...

Jazz Pharmaceuticals asserted the enrollment of patients in a Phase 2 Clinical Trial evaluating the efficacy and safety of defibrotide for the prevention of acute…
Read More...

Stephen Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine on National Toxicology Program draft report on Bisphenol A stating that "We base our regulatory decisions on…
Read More...

Leading innovator in  treatments for atrial fibrillation (Afib), AtriCure and left atrial appendage management (LAAM) announced the rolling out of AtriClip FLEX•V Left Atrial Appendage…
Read More...

Aurinia Pharmaceuticals which is a clinical stage bio pharmaceutical company aiming to enhance its global immunology market appointed Michael Hayden,CM OBC MB ChB PhD FRCP (C) FRSC to…
Read More...

Pfizer claimed the appointment of Albert Bourla, DVM,Ph.D to its Board off Directors with effect from immediately. Dr.Albert Bourla is currently the Chief operating officer of…
Read More...